Robert S. Laitman, MD, discusses evidence supporting the reclassification of schizophrenia as a neurological disorder, his views on how reclassification could impact prognosis and recovery, and treatment interventions he says have led to meaningful recovery in his patients with schizophrenia. For more, visit www.consultant360.com.